Mirum Pharmaceuticals, Inc. - common stock (NQ:MIRM)

86.54 +4.94 (+6.05%)

Streaming Delayed Price Updated: 3:49 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Volume	620,091
Open	82.01
Bid (Size)	86.51 (200)
Ask (Size)	86.57 (200)
Prev. Close	81.60
Today's Range	81.62 - 86.79
52wk Range	36.88 - 83.75
Shares Outstanding	38,297,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 07, 2026

From Mirum Pharmaceuticals, Inc.

Via Business Wire

5 Predictions for the Stock Market in 2026 -- and Which Stocks Will Soar the Most If They're Right ↗

January 04, 2026

Not all of these predictions may come true. But at least a few of them will likely do so.

Via The Motley Fool

Performance

YTD	+10.8%	+10.8%
1 Month	+32.3%	+32.3%
3 Month	+17.2%	+17.2%
6 Month	+63.3%	+63.3%
1 Year	+106.0%	+106.0%

More News

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Shows Strong Growth Momentum and Bullish Technical Setup ↗

January 01, 2026

Via Chartmill

Prediction: 3 Stocks That Will Be Worth More Than Newsmax 5 Years From Now ↗

December 30, 2025

Via The Motley Fool

Mirum Stock Slips On $820M Bluejay Deal — But Wall Street Calls The Hepatitis Drug Seal A 'Steal' ↗

December 08, 2025

Via Stocktwits

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗

December 28, 2025

Via The Motley Fool

Mirum Pharmaceuticals Announces Additional Private Placement Financing With TCGX

December 19, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 10, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics, Expanding Global Leadership in Rare Disease

December 08, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Prediction: This Stock Has Soared Nearly 70% in 2025 and Will Be an Even Bigger Winner in 2026 ↗

December 03, 2025

Via The Motley Fool

Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? ↗

December 02, 2025

Via The Motley Fool

Mirum Pharmaceuticals Announces First Patient Enrolled in the BLOOM Phase 2 Clinical Study Evaluating MRM-3379 in Fragile X Syndrome

December 01, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

MIRUM PHARMACEUTICALS INC (NASDAQ:MIRM) Shows Strong Growth Momentum and Bullish Technical Setup ↗

November 29, 2025

Via Chartmill

Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% ↗

November 27, 2025

Via The Motley Fool

Why This Private Equity-Style Fund Just Bet $17 Million on Lumen Technologies Stock ↗

November 27, 2025

Via The Motley Fool

Penn Capital Unwinds $17.1 Million BGC Stake as Broker Posts 31% Revenue Surge ↗

November 27, 2025

Via The Motley Fool

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

November 25, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 10, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®

November 07, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

What Analysts Are Saying About Mirum Pharmaceuticals Stock ↗

November 05, 2025

Via Benzinga

Mirum Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

November 04, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

November 03, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

October 28, 2025

From Mirum Pharmaceuticals, Inc.

Via Business Wire

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Presents a Compelling Growth Momentum and Technical Setup ↗

October 18, 2025

Via Chartmill

Frequently Asked Questions

Is Mirum Pharmaceuticals, Inc. - common stock publicly traded?

Yes, Mirum Pharmaceuticals, Inc. - common stock is publicly traded.

What exchange does Mirum Pharmaceuticals, Inc. - common stock trade on?

Mirum Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Mirum Pharmaceuticals, Inc. - common stock?

The ticker symbol for Mirum Pharmaceuticals, Inc. - common stock is MIRM on the Nasdaq Stock Market

What is the current price of Mirum Pharmaceuticals, Inc. - common stock?

The current price of Mirum Pharmaceuticals, Inc. - common stock is 86.54

When was Mirum Pharmaceuticals, Inc. - common stock last traded?

The last trade of Mirum Pharmaceuticals, Inc. - common stock was at 01/09/26 03:49 PM ET

What is the market capitalization of Mirum Pharmaceuticals, Inc. - common stock?

The market capitalization of Mirum Pharmaceuticals, Inc. - common stock is 3.31B

How many shares of Mirum Pharmaceuticals, Inc. - common stock are outstanding?

Mirum Pharmaceuticals, Inc. - common stock has 3B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.